CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 36 enrolled
Drug / intervention
Tranexamic Acid +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02664909
NCT02664909Phase 4Completed
CompareCT.gov

Topical (Intra-Articular) Tranexamic Acid and Transfusion Rates Following Hip Hemiarthroplasty

UConn Health·interventional·Posted Jan 27, 2016·Updated Jul 22, 2021

In Brief

A Phase 4 clinical trial evaluating Tranexamic Acid and Placebo (saline) for Femoral Neck Fractures. Completed, enrolled 36 participants across 2 sites.

Detailed Summary

This study is a double-blinded placebo-controlled clinical trial evaluating the efficacy of 1 gram of topically applied tranexamic acid vs. saline placebo for the reduction of transfusion following hip hemiarthroplasty surgery.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsFemoral Neck Fractures
CountriesUnited States
CollaboratorsOrthopedic Research and Education Foundation

Timeline

Phase 4CompletedFinished
20162017201820192020202120222023202420252026
First PostedJan 27, 2016
Enrollment StartJan 1, 2016
Primary CompletionJun 30, 2019
TodayJul 2, 2026
Enrollment to primary: 3.5 yearsPosted 10.4 years ago

Interventions

Tranexamic Aciddrug

Placebo (saline)drug